KURA
Price
$11.04
Change
-$0.69 (-5.88%)
Updated
Sep 23 closing price
Capitalization
1.04B
35 days until earnings call
Intraday BUY SELL Signals
MGTX
Price
$11.75
Change
-$0.60 (-4.86%)
Updated
Sep 23 closing price
Capitalization
1.19B
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KURA vs MGTX

KURA vs MGTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KURA vs. MGTX commentary
Sep 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a Hold and MGTX is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
KURA vs MGTX: Fundamental Ratings
KURA
MGTX
OUTLOOK RATING
1..100
8657
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9917
PRICE GROWTH RATING
1..100
4141
P/E GROWTH RATING
1..100
10042
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KURA's Valuation (64) in the Biotechnology industry is in the same range as MGTX (72). This means that KURA’s stock grew similarly to MGTX’s over the last 12 months.

KURA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MGTX (100). This means that KURA’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's SMR Rating (17) in the Biotechnology industry is significantly better than the same rating for KURA (99). This means that MGTX’s stock grew significantly faster than KURA’s over the last 12 months.

MGTX's Price Growth Rating (41) in the Biotechnology industry is in the same range as KURA (41). This means that MGTX’s stock grew similarly to KURA’s over the last 12 months.

MGTX's P/E Growth Rating (42) in the Biotechnology industry is somewhat better than the same rating for KURA (100). This means that MGTX’s stock grew somewhat faster than KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KURAMGTX
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
82%
Bearish Trend 1 day ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 1 day ago
84%
COMPARISON
Comparison
Sep 24, 2026
Stock price -- (KURA: $11.04 vs. MGTX: $11.75)
Brand notoriety: KURA and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 166% vs. MGTX: 195%
Market capitalization -- KURA: $1.04B vs. MGTX: $1.19B
KURA [@Biotechnology] is valued at $1.04B. MGTX’s [@Biotechnology] market capitalization is $1.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.53B. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 0 FA rating(s) are green while MGTX’s FA Score has 1 green FA rating(s).

  • KURA’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, MGTX is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 5 TA indicator(s) are bullish while MGTX’s TA Score has 5 bullish TA indicator(s).

  • KURA’s TA Score: 5 bullish, 5 bearish.
  • MGTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both KURA and MGTX are a good buy in the short-term.

Price Growth

KURA (@Biotechnology) experienced а -1.43% price change this week, while MGTX (@Biotechnology) price change was -7.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.56%. For the same industry, the average monthly price growth was -9.72%, and the average quarterly price growth was +7.23%.

Reported Earning Dates

KURA is expected to report earnings on Oct 29, 2026.

MGTX is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (-0.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
KURA
Daily Signal:
Gain/Loss:
MGTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPWCX9.870.04
+0.41%
American Beacon Stephens Sm Cp Gr C
TGVLX61.880.15
+0.24%
Touchstone Dynamic Large Cap Growth R6
JEPAX14.060.02
+0.14%
JPMorgan Equity Premium Income A
CWICX82.400.08
+0.10%
American Funds Cptl Wld Gr&Inc 529-C
FMUCX16.65-0.01
-0.06%
Federated Hermes Muni and Stock Adv C

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with XNCR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
+1.12%
XNCR - KURA
53%
Loosely correlated
+0.52%
IMVT - KURA
52%
Loosely correlated
+0.30%
VIR - KURA
49%
Loosely correlated
+5.70%
RLAY - KURA
48%
Loosely correlated
+6.38%
DYN - KURA
47%
Loosely correlated
+0.12%
More